Active substance
Prochlorperazine
- US FDA 59
- Health Canada 3
- US price lines 4
- NHS prices 3
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | HIKMA PHARMS | Prescription | 29 Aug 1989 |
| PROCHLORPERAZINE | 25MG | suppository · rectal | COSETTE PHARMS NC | Prescription | 24 Nov 1993 |
| PROCOMP | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | JUBILANT CADISTA | Prescription | 27 Feb 1998 |
| COMPRO | 25MG | suppository · rectal | PADAGIS US | Prescription | 28 Jun 2000 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | SAGENT | Prescription | 28 May 2004 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | AVET LIFESCIENCES | Prescription | 15 Oct 2013 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | MYLAN LABS LTD | Prescription | 25 Oct 2018 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | CAPLIN | Prescription | 22 Apr 2021 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | GLAND | Prescription | 22 Sep 2021 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | VIWIT PHARM | Prescription | 28 Sep 2021 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | NOVITIUM PHARMA | Prescription | 13 Jun 2022 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | EUGIA PHARMA | Prescription | 14 Jul 2022 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 8 Aug 2022 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | GLENMARK PHARMS LTD | Prescription | 17 Mar 2023 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | BIONPHARMA | Prescription | 4 Apr 2023 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | AMNEAL | Prescription | 17 Apr 2023 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | AJANTA PHARMA LTD | Prescription | 9 May 2024 |
| PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | injectable · injection | SOMERSET THERAPS LLC | Prescription | 13 Sep 2024 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | LEADING | Prescription | 30 Sep 2024 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | DR REDDYS LABS SA | Prescription | 19 May 2025 |
| PROCHLORPERAZINE MALEATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 8 Sep 2025 |
| COMPAZINE | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | GLAXOSMITHKLINE | Discontinued | 23 Oct 1956 |
| COMPAZINE | EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | GLAXOSMITHKLINE | Discontinued | 8 Apr 1957 |
| COMPAZINE | EQ 10MG BASE; EQ 15MG BASE; EQ 30MG BASE; EQ 75MG BASE | capsule, extended release · oral | GLAXOSMITHKLINE | Discontinued | 5 Jun 1957 |
| COMPAZINE | EQ 5MG BASE/5ML | syrup · oral | GLAXOSMITHKLINE | Discontinued | 10 Dec 1957 |
34 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ODAN-PROCHLORPERAZINE | 00789720 | 10 MG | SUPPOSITORY · RECTAL | ODAN LABORATORIESLTD |
| PROCHLORAZINE | 00886432 | 10 MG | TABLET · ORAL | AA PHARMA INC |
| PROCHLORAZINE | 00886440 | 5 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | COMPRO 25 MG SUPPOSITORY | $6.74227 | per EA | 23 Sep 2026 |
| US NADAC | PROCHLORPERAZINE 10 MG TAB | $0.16215 | per EA | 23 Sep 2026 |
| US NADAC | PROCHLORPERAZINE 25 MG SUPP | $4.86511 | per EA | 23 Sep 2026 |
| US NADAC | PROCHLORPERAZINE 5 MG TABLET | $0.11478 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Prochlorperazine 12.5mg/1ml solution for injection ampoules | £5.23 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Prochlorperazine 3mg buccal tablets | £16.56 | 50 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Prochlorperazine 5mg tablets | £0.93 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.